Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer.

Innamaa, A

Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer. [electronic resource] - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Nov 2013 - 910-8 p. digital

Publication Type: Comparative Study; Journal Article

1699-3055

10.1007/s12094-013-1022-4 doi


Adenocarcinoma, Clear Cell--drug therapy
Adenocarcinoma, Mucinous--drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Biomarkers, Tumor--metabolism
Blotting, Western
Case-Control Studies
Cell Proliferation--drug effects
Cells, Cultured
Curcumin--pharmacology
Cystadenocarcinoma, Serous--drug therapy
Endometrial Neoplasms--drug therapy
Female
Flow Cytometry
Fluorescent Antibody Technique
Follow-Up Studies
Humans
Immunoenzyme Techniques
Male
Middle Aged
Neoplasm Grading
Ovarian Neoplasms--drug therapy
Ovary--drug effects
Potassium Channels, Tandem Pore Domain--metabolism
Prognosis
Survival Rate